The CHEK2 variant C.349A>G is associated with prostate cancer risk and carriers share a common ancestor

The identification of recurrent founder variants in cancer predisposing genes may have important implications for implementing cost-effective targeted genetic screening strategies. In this study, we evaluated the prevalence and relative risk of the <i>CHEK2</i> recurrent...

全面介紹

書目詳細資料
Main Authors: Brandão, A, Paulo, P, Maia, S, Pinheiro, M, Peixoto, A, Cardoso, M, Silva, MP, Santos, C, Eeles, RA, Kote-Jarai, Z, Muir, K, Ukgpcs Collaborators, Schleutker, J, Wang, Y, Pashayan, N, Batra, J, Apcb BioResource, Grönberg, H, Neal, DE, Nordestgaard, BG, Tangen, CM, Southey, MC, Wolk, A, Albanes, D, Haiman, CA, Travis, RC, Stanford, JL, Mucci, LA, West, CML, Nielsen, SF, Kibel, AS, Cussenot, O, Berndt, SI, Koutros, S, Sørensen, KD, Cybulski, C, Grindedal, EM, Park, JY, Ingles, SA, Maier, C, Hamilton, RJ, Rosenstein, BS, Vega, A, The Impact Study Steering Committee And Collaborators, Kogevinas, M, Wiklund, F, Penney, KL, Brenner, H, John, EM, Kaneva, R
格式: Journal article
語言:English
出版: MDPI 2020